Free Fetal DNA in Maternal Plasma in Anembryonic Pregnancies: Confirmation That the Origin is the Trophoblast
Overview
Affiliations
Objective: To test the hypothesis that free fetal DNA (ffDNA) circulating in maternal plasma originates mainly from the placenta we studied ffDNA levels in anembryonic pregnancies.
Methods: Maternal blood samples were collected from 15 normal first-trimester pregnancies in which fetal sex was subsequently determined and nine patients with a diagnosis of anembryonic gestation (AG). The Y chromosome DYS14 gene was quantified by real-time quantitative PCR (RT-PCR) for the determination of fetal sex in both plasma and chorionic tissue samples. Fetal sex in chorionic tissue samples was also determined using quantitative fluorescence PCR (QF-PCR).
Results: The correct sex result was obtained from maternal plasma in all. Four AG pregnancies were female (DYS14 negative) results. In five of the AG cases, the chorionic tissue was found to be male (by both QF-PCR and RT-PCR which agreed) and positive male signal was found in maternal plasma by RT-PCR. There was no statistical difference between median free fetal DNA concentration in plasma between the AG male cases (148.3 GE/mL) and controls (145.8 GE/mL).
Conclusion: Since ffDNA levels are normal in pregnancies without a fetus, the data support the hypothesis that the trophoblastic cells are the major source ffDNA in maternal plasma.
Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.
Hanson B, Paternoster B, Povarnitsyn N, Scotchman E, Chitty L, Chandler N Extracell Vesicles Circ Nucl Acids. 2024; 4(1):3-26.
PMID: 39698301 PMC: 11648410. DOI: 10.20517/evcna.2022.44.
Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility.
Che H, Stanley K, Jatsenko T, Thienpont B, Vermeesch J Extracell Vesicles Circ Nucl Acids. 2024; 3(3):216-234.
PMID: 39697489 PMC: 11648412. DOI: 10.20517/evcna.2022.21.
Cell-free placental DNA: What do we really know?.
Yuen N, Lemaire M, Wilson S PLoS Genet. 2024; 20(12):e1011484.
PMID: 39652523 PMC: 11627368. DOI: 10.1371/journal.pgen.1011484.
Evaluation of the clinical utility of NIPT-plus and analysis of adverse pregnancy outcomes.
Zhang L, Chang B, Wang L, Mijiti G, Bahetibieke K, Xue S Arch Gynecol Obstet. 2024; 310(6):2973-2981.
PMID: 39505749 DOI: 10.1007/s00404-024-07811-9.
De Falco A, Gambale A, Pinelli M, Suero T, De Falco L, Iolascon A Cells. 2024; 13(13.
PMID: 38994932 PMC: 11240558. DOI: 10.3390/cells13131078.